Whitepaper: Drug shortages – why do they happen and how can we stop them?
Posted: 17 February 2020 | NSF | No comments yet
This whitepaper from NSF looks at the key causes of drug shortages and what we can do to stop them.
With 56 percent of U.S. health care providers reporting to have changed patient care or delayed therapy as a result of drug shortages, this white paper from NSF looks at the key reasons behind the issue and what you can do to stop it.
Related content from this organisation
- NSF’s quality management maturity (QMM) assessment model
- Regulatory Authority Inspection Comparison
- Whitepaper: What to expect from a regulatory inspection, an NSF expert guide
- Whitepaper: Optimise organisational culture & quality maturity
- Whitepaper: Drug shortages – why do they happen and how can we stop them?
Related topics
Biopharmaceuticals, Formulation, Manufacturing, QA/QC, Research & Development (R&D)
